Skip to product information
1 of 1

MULTI SCIENCES

Human Apolipoprotein H/Apo H ELISA Kit Distributor

Human Apolipoprotein H/Apo H ELISA Kit Distributor

SKU:EK1193

Regular price Send Inquiry
Regular price Sale price Send Inquiry
Sale Sold out
View full details

Product Details

Human Apolipoprotein H/Apo H ELISA Kit Distributor

Brand

MultiSciences

Cat Num

70-EK1193

Product Name

Human Apolipoprotein H/Apo H ELISA Kit

Customs Name

Human Apolipoprotein H/Apo H ELISA Kit

Application

ELISA

Reactivity

Human

Assay Type

Sandwich ELISA

Suitable Sample Type

serum, plasma, cell culture supernates

Format

96-well strip plate

Storage

4℃ (unopened)standard stored at -20℃, others stored at 4℃ (opened)

Shipping Condition

4℃

Sample Volume

50 μl

Sensitivity

16.18 pg/ml

Standard Curve Range

125 - 8000 pg/ml

Spike Recovery Range

-

Mean Spike Recovery

-

CV of Intra plate

2.4 % - 6.3 %

CV of Inter plate

3.9 % - 4.6 %

Components

96-well polystyrene microplate coated with a monoclonal antibody against Apo H
Human Apo H Standard, lyophilized
Apo H Detect Antibody
Assay Buffer (10×)
Substrate (TMB)
Stop Solution
Washing Buffer (20×)
Plate Covers

Describtion

This assay employs the quantitative sandwich enzyme immunoassay technique for the quantitative detection of human Apo H. The Human Apolipoprotein H/Apo H ELISA is for research use only. Not for diagnostic or therapeutic procedures.
Apolipoprotein H (Apo H), previously known as β2-glycoprotein I, is a multifunctional apolipoprotein that in humans is encoded by the APOH gene. It is a glycoprotein synthesized by liver cells. One of its functions is to bind cardiolipin. Apo H binds to various kinds of negatively charged substances such as heparin, phospholipids, and dextran sulfate. Apo H has a complex involvement in agglutination, it appears to alter ADP mediated agglutination of platelets. It may prevent activation of the intrinsic blood coagulation cascade by binding to phospholipids on the surface of damaged cells. Normally Apo H assumes an anti-coagulation activity in serum (by inhibiting coagulation factors). Its plasma concentrations are strongly associated to metabolic syndrome alterations and vascular disease in type 2 diabetic and could be considered as a clinical marker of cardiovascular risk.